713-1043

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
713 (USA) · Dr. Kowalski
consented 2013-09-15

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-26 (study day 12.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-26 (study day 12.0); relationship: PROBABLE

mild assessed

Mild CATARACT OPERATION — outcome: RECOVERED/RESOLVED; onset 2014-03-08 (study day 175.0); relationship: NONE

moderate assessed

Moderate NAUSEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

moderate assessed

Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

moderate assessed

Moderate VOMITING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

moderate assessed

Moderate VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 27.0); relationship: POSSIBLE

Data queries

No data queries.